Auld, B.A., and L. Morin. 1995. Constraints in the development of bioherbicides. Weed Technol. 9(3):638-652.

Azor, M., J. Cano, J. Gene, and J. Guarro. 2009. High genetic diversity and poor in vitro response to antifungals of clinical strains of Fusarium oxysporum. J. Antimicrob. Chemother. 63(6):1152-1155.

Baayen, R.P., K. O’Donnell, P.J.M. Bonants, E. Cigelnik, P.N. Laurens, M. Kroon, E.J.A. Roebroeck, and C. Waalwijk. 2000. Gene genealogies and AFLP analyses in the Fusarium oxysporum complex identify monophyletic and nonmonophyletic formae speciales causing wilt and rot disease. Phytopathology 90(8):891-900.

Bacon, C.W., J.K. Porter, W.P. Norred, and J.F. Leslie. 1996. Production of fusaric acid by Fusarium species. Appl. Environ. Microbiol. 62(11):4039-4043.

Bailey, B.A., K.P. Hebbar, M. Strem, L.C. Darlington, and R.D. Lumsden. 1997. An alginate prill formulation of Fusarium oxysporum Schlechtend:Fr. f.sp. erythroxyli for biocontrol of Erythroxylum coca var. coca. Biocontrol Sci. Technol. 7(3):423-435.

Bailey, B.A., K.P. Hebbar, M. Strem, R.D. Lumsden, L.C. Darlington, W.J. Connick, Jr., and D.J. Daigle. 1998. Formulations of Fusarium oxysporum f.sp. erythroxyli for biocontrol of Erythroxylum coca var. coca. Weed Sci. 46(6):682-689.

Bailey, B.A., P.C. Apel-Birkhold, O.O. Akingbe, J.L. Ryan, N.R. O’Neill, and J. Anderson. 2000a. Nep1 protein from Fusarium oxysporum enhances biological control of opium poppy by Pleospora papaveracea. Phytopathology 90(8):812-818.

Bailey, B.A., P.C. Apel-Birkhold, N.R. O’Neill, J. Plaskowitz, S. Alavi, J.C. Jennings, and J.D. Anderson. 2000b. Evaluation of infection processes and resulting disease caused by Dendryphion penicillatum and Pleospora papaveracea on Papaver somniferum. Phytopathology 90(7):699-709.

Bailey, B.A., K.P. Hebbar, R.D. Lumsden, N.R. O’Neill, and J.A. Lewis. 2004a. Production of Pleospora papaveracea biomass in liquid culture and its infectivity on opium poppy (Papaver somniferum). Weed Sci. 52(1):91-97.

Bailey, B.A., N.R. O’Neill, and J.D. Anderson. 2004b. Influence of adjuvants on disease development by Pleospora papaveracea on opium poppy (Papaver somniferum). Weed Sci. 52(3):424-432.

Baran, R. 1997. Uncommon clinical patterns of Fusarium nail infection: Report of three cases. Br. J. Dermatol. 136(3):424-427.

Bailey, K.L., and S. Falk. Turning research on microbial bioherbicides into commercial products—A Phoma story, Pest. Technol. (in press).

Baudoin, A.B., R.G. Abad, L.T. Kok, and W.L. Bruckart. 1993. Field evaluation of Puccinia carduorum for biological control of musk thistle. Biol. Control 3(1):53-60.

Bennett, A. 1873. An experimental inquiry into the physiological action of theine, caffeine, guaranine, cocaine, and theobromine. Edinb. Med. J. 19(1):323-341.

Berkoff, J. 2007. The opium economy: A possible approach to reform. World Econ. 8(4):9-45.

Berner, D.K., and W.L. Bruckart. 2005. A decision tree for evaluation of exotic plant pathogens for classical biological control of introduced invasive weeds. Biol. Control 34(2):222-232.

Bhattacharji, R. 2007. India’s Experiences in Licensing Poppy Cultivation for the Production of Essential Medicines: Lessons for Afghanistan. Poppy for Medicine Project, The International Council on Security and Development [online]. Available: http://www.poppyformedi133cine.net/modules/support/documents/india_case_study [accessed on Dec. 15, 2010].



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement